Developer docs
API playgroundTry for free, no card

Search company profiles

Uncancer

Full company profile

uuid00srpkq

Namestring
Uncancer
Legal namestring
Uncancer LLC
Websiteurl
uncancer.com
Company typeenum
Private
Founded yearint
2020
Descriptiontext

Uncancer LLC designs and sells oral care and adaptive apparel products for people undergoing cancer treatment. The oral care (OC) line is built on nano-Hydroxyapatite (nHAP) fluoride-free formulations intended to address chemotherapy-induced dry mouth, tooth sensitivity, mucositis, and cracked lips, and includes a Sensitive Teeth Kit, Dry Mouth Kit, Toothpaste, Soothing Mouth Rinse, Dry Mouth Candies, Lip Balm, and Remineralization Gel. The Comfort Wear (CW) line offers adaptive shirts, pants, caps, beanies, and a port-friendly Comfort Shield designed to ease treatment visits. Products are sold direct-to-consumer through a Shopify storefront at uncancer.com with optional monthly subscription kits, at price points ranging from $10 to $85 per item.

The company operates a dual go-to-market. The DTC motion is content-led, with an extensive blog, patient checklists, podcast appearances, and organic social driving traffic to the e-commerce site. The enterprise motion is delivered through OSEM (Oncology Side Effect Management), a value-based care platform housed under Reliefco that combines AI-driven claims intelligence, home delivery of preventive oral care, RN navigation, and actuarial outcome measurement for health plan and pharma partners. Enterprise economics are structured around an illustrative $220 PMPM program cost with a shared-savings component retaining 75% of documented savings for the health plan, yielding illustrative ROI of 2.0x-3.3x for high-risk oncology cohorts under multi-year contracts.

Uncancer was founded in 2020 by Dr. Abida Taher, MD, PhD and Dr. Robyn Lesser, MD, PhD, and is incorporated in New York with operating headquarters in Dunedin, Florida. The company is privately held, has 1-10 employees, and reports no external funding. Disclosed enterprise traction includes a prior national Cigna Medicare Advantage deployment that enrolled 4,022 oncology patients and a strategic collaboration with Daiichi Sankyo and AstraZeneca to support oral toxicity prevention for the Dato-DXd ADC therapy.

Short descriptiontext

Uncancer provides doctor-formulated oral care products and adaptive apparel designed for cancer patients managing chemotherapy side effects, distributed DTC via Shopify and through OSEM value-based care partnerships with health plans and pharma companies.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersClearwater, United States
HQ citystring
Clearwater
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
oncology oral care, adaptive chemo apparel, cancer symptom management, value-based oncology care, specialty dental products
Industry1 code
PRIMARYCRADAMAD
Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)
NAICS code2 codes
  • Cosmetics, Beauty Supplies, and Perfume Retailers456120
  • Health and Personal Care Retailers456
SIC code2 codes
  • Perfumes, Cosmetics & Other Toilet Preparations2844
  • Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics2840
Product category
Oncology Support Products
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Product Sales (Oral Care & Comfort Wear)
TypeOne Time License
Description

Direct-to-consumer e-commerce sales of oral care products (toothpaste, mouth rinse, dry mouth candies, lip balm, remineralization gel, sensitive teeth kits, dry mouth kits) and comfort wear apparel (adaptive shirts, pants, hats, port protectors) for cancer patients. One-time purchase and subscription options available.

uncancer.com
2Subscription Plans
TypeSubscription Recurring
Description

Monthly subscription model delivering oral care kits every 30 days. Customers receive invoices with checkout links for recurring orders. Kits can be customized based on patient needs.

uncancer.com
3Value-Based Care Partnerships (B2B)
TypeManaged Services
Description

OSEM platform partnerships with health plans and pharma companies. Combines PMPM operating model with shared-savings alignment where Uncancer participates in upside only when documented cost reductions are achieved in oncology side effect management.

uncancer.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components1 value
Supply Chain
Pricing details3 tiers
1Individual oral care and comfort wear products
ModelUnit PricingBilling cadencePay-as-you-go
Notes

OC Sensitive Teeth Kit: $50, OC Dry Mouth Kit: $55, OC Toothpaste (2-pack): $40, OC Dry Mouth Candies (6-pack): $35, OC Lip Balm (3-pack): $10, OC Remineralization Gel (2-pack): $20, CW Flex Pant: $60, CW Adaptive Crew Men: $85, CW Adaptive Crew Women: price varies, CW Baseball Cap: price varies, CW Cozy Beanie: price varies, CW Comfort Shield: price varies. Gift cards available.

uncancer.com
2Monthly subscription for oral care kits
ModelSubscriptionBilling cadenceMonthly
Notes

Choose your kit, signup for monthly subscription, delivered every 30 days. Invoice sent with checkout link when recurring order is due. Payment completes before shipping.

uncancer.com
3OSEM Enterprise Value-Based Care Program
ModelOtherBilling cadenceMulti-year contract
Notes

$220 illustrative all-in PMPM program cost. Shared savings model: 75% documented savings retained by health plan. 2.0x-3.3x illustrative ROI range for high-risk oncology cohorts. Contact for pilot pricing.

uncancer.com
GTM typeB2B and B2C
B2B and B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Uncancer sells doctor- and dentist-formulated oral care products and adaptive comfort apparel designed for people undergoing cancer treatment. The Oral Care (OC) line uses proprietary nHAP (nano-Hydroxyapatite) fluoride-free formulations to address chemo-induced dry mouth, tooth sensitivity, mucositis, and cracked lips. The Comfort Wear (CW) line provides adaptive clothing with port access and dignity features for treatment visits and everyday wear. Products are sold direct-to-consumer via a Shopify storefront with one-time purchase and monthly subscription options.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 4,022 oncology patients enrolled in prior Cigna Medicare Advantage deployment with strong patient-reported symptom relief and satisfaction
+3 more records
Product overview1 text field

Uncancer is a direct-to-consumer e-commerce company offering two integrated product collections — Oral Care (OC) and Comfort Wear (CW) — for cancer patients and their caregivers. The OC portfolio comprises nHAP fluoride-free oral care products (Sensitive Teeth Kit, Dry Mouth Kit, Dry Mouth Candies, Soothing Mouth Rinse, Toothpaste, Lip Balm, and Remineralization Gel) designed by doctors and dentists to address chemo-induced oral side effects. The CW portfolio consists of adaptive apparel (Adaptive Crew shirts for men and women, Comfort Shield, Flex Pant, Baseball Cap, and Cozy Beanie) engineered to ease treatment visits and accommodate medical devices. The company also operates OSEM™, a value-based care platform division serving health plans and pharma partners with claims-driven patient identification, home delivery of preventive products, RN navigation, and outcomes measurement. The broader offering includes educational blog content, stress-less checklists, and gift cards.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership13 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Prior national payer deployment enrolled 4,022 oncology patients under OSEM value-based care model. Generated strong patient-reported symptom relief and satisfaction outcomes. Demonstrated feasibility of preventive oral care intervention at scale.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Uncancer selected to support oral toxicity prevention for Dato-DXd, one of the highest oral-burden ADC therapies. Protocol activates at treatment initiation with no referral or prior authorization burden. Designed to protect treatment continuity.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Non-profit organization providing financial support to breast cancer patients. Partner logo displayed on Uncancer trusted partners page.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Breast cancer organization. Partner logo displayed on Uncancer trusted partners page.

5American Cancer Society
Strategic tierMinorTypeGTM or Marketing Partner
Description

Via Side Effect Support partnership. Partner logo displayed on Uncancer trusted partners page.

uncancer.com
Strategic tierMinorTypeGTM or Marketing Partner
Description

Professional organization for oncology nurses. Partner logo displayed on Uncancer trusted partners page.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Non-profit dedicated to oral cancer awareness and support. Partner logo displayed on Uncancer trusted partners page.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Jewish breast cancer organization supporting women and families. Partner logo displayed on Uncancer trusted partners page.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Breast cancer support organization. Partner logo displayed on Uncancer trusted partners page.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Organization helping women feel fierce and beautiful during cancer treatment. Partner logo displayed on Uncancer trusted partners page.

Strategic tierMinorTypeGTM or Marketing Partner
Description

BRCA mutation awareness and support organization. Partner logo displayed on Uncancer trusted partners page.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Dental distribution company. Partner logo displayed on Uncancer trusted partners page.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Cigna Starter Kit available for Cigna members. Partnership for providing oral care solutions to oncology patients.

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Thyme Care is an oncology-focused value-based care navigation company working with health plans to reduce total cost of care for cancer patients. It is an adjacent emerging player in the same payer-facing oncology support category as Uncancer's OSEM division.

2Pack Health
TypeEmerging player
Description

Pack Health is a digital health coaching company that partners with pharma and payers on condition-specific patient engagement and outcomes measurement. It overlaps with Uncancer's OSEM model in payer- and pharma-facing outcomes-driven engagement, though it does not focus on oncology oral care products.

TypeBroad incumbent
Description

Procter & Gamble operates Crest and Oral-B, the leading mass-market oral care franchises with deep dental professional endorsement and clinical research infrastructure. It is the primary broad-incumbent competitor in the fluoride and sensitivity toothpaste category where Uncancer's OC Sensitive Teeth Kit competes.

TypeBroad incumbent
Description

Tom's of Maine is a Colgate-Palmolive-owned natural oral care brand selling fluoride-free toothpaste and mouth rinses through mass retail. It is a broad incumbent in the same natural-ingredient oral care category as Uncancer's OC line, though it lacks the oncology-specific positioning.

TypeDirect peer
Description

Boka is a direct-to-consumer oral care brand built around nano-hydroxyapatite (nHAP) fluoride-free formulations — the same core ingredient technology Uncancer uses. It targets mainstream consumers rather than oncology patients, but the formulation overlap, channel model, and ingredient positioning make it the closest comparable.

TypeDirect peer
Description

Care+Wear is a direct-to-consumer adaptive apparel brand designed for patients undergoing medical treatment, including port access and recovery needs. It is the most directly comparable peer to Uncancer's Comfort Wear collection, competing in the same niche.

TypeBroad incumbent
Description

Burt's Bees is a Clorox-owned natural personal care brand with adjacent lip balm and skincare offerings that overlap with Uncancer's OC Lip Balm and oral care portfolio. It is a broader incumbent rather than a direct oncology competitor, but competes for the same natural-ingredient-conscious buyer.

TypeDirect peer
Description

Hello is a natural-ingredient oral care brand selling toothpaste, mouth rinse, and breath products direct-to-consumer via e-commerce. It competes in the same natural, free-from positioning that Uncancer's OC line occupies, though without the oncology-specific clinical framing.

TypeBroad incumbent
Description

Colgate-Palmolive is the dominant global oral care incumbent with extensive R&D, retailer relationships, and clinical programs. While it does not focus on oncology-specific formulations, its scale and ability to launch condition-specific sub-brands represent the primary competitive ceiling for Uncancer's OC line.

TypeEmerging player
Description

Carifree is a dental-products company focused on cavity prevention and remineralization technology, with professional dental channel distribution. It overlaps with Uncancer's nHAP remineralization positioning and is a relevant emerging player in the specialty oral care space.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration6 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Uncancer

Oncology Support Productsuncancer.com

Uncancer provides doctor-formulated oral care products and adaptive apparel designed for cancer patients managing chemotherapy side effects, distributed DTC via Shopify and through OSEM value-based care partnerships with health plans and pharma companies.

What Uncancer does

Uncancer LLC designs and sells oral care and adaptive apparel products for people undergoing cancer treatment. The oral care (OC) line is built on nano-Hydroxyapatite (nHAP) fluoride-free formulations intended to address chemotherapy-induced dry mouth, tooth sensitivity, mucositis, and cracked lips, and includes a Sensitive Teeth Kit, Dry Mouth Kit, Toothpaste, Soothing Mouth Rinse, Dry Mouth Candies, Lip Balm, and Remineralization Gel. The Comfort Wear (CW) line offers adaptive shirts, pants, caps, beanies, and a port-friendly Comfort Shield designed to ease treatment visits. Products are sold direct-to-consumer through a Shopify storefront at uncancer.com with optional monthly subscription kits, at price points ranging from $10 to $85 per item.

The company operates a dual go-to-market. The DTC motion is content-led, with an extensive blog, patient checklists, podcast appearances, and organic social driving traffic to the e-commerce site. The enterprise motion is delivered through OSEM (Oncology Side Effect Management), a value-based care platform housed under Reliefco that combines AI-driven claims intelligence, home delivery of preventive oral care, RN navigation, and actuarial outcome measurement for health plan and pharma partners. Enterprise economics are structured around an illustrative $220 PMPM program cost with a shared-savings component retaining 75% of documented savings for the health plan, yielding illustrative ROI of 2.0x-3.3x for high-risk oncology cohorts under multi-year contracts.

Uncancer was founded in 2020 by Dr. Abida Taher, MD, PhD and Dr. Robyn Lesser, MD, PhD, and is incorporated in New York with operating headquarters in Dunedin, Florida. The company is privately held, has 1-10 employees, and reports no external funding. Disclosed enterprise traction includes a prior national Cigna Medicare Advantage deployment that enrolled 4,022 oncology patients and a strategic collaboration with Daiichi Sankyo and AstraZeneca to support oral toxicity prevention for the Dato-DXd ADC therapy.

Uncancer firmographics

Firmographics
Name
Uncancer
Legal name
Uncancer LLC
Website
https://uncancer.com
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
1–10 employees
Short description
Uncancer provides doctor-formulated oral care products and adaptive apparel designed for cancer patients managing chemotherapy side effects, distributed DTC via Shopify and through OSEM value-based care partnerships with health plans and pharma companies.
Ownership category
akta.pro rank

Uncancer industry classification

Industry
Product category
Oncology Support Products
NAICS
Cosmetics, Beauty Supplies, and Perfume Retailers (456120), Health and Personal Care Retailers (456)
SIC
Perfumes, Cosmetics & Other Toilet Preparations (2844), Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics (2840)
akta.pro industry
PRIMARYCRADAMAD
Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)

Keywords

  • Oncology oral care
  • Adaptive chemo apparel
  • Cancer symptom management
  • Value-based oncology care
  • Specialty dental products

Where Uncancer is headquartered

Location

Headquarters

HQ city
Clearwater
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Uncancer business model

Business model
GTM type
B2B and B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain

Revenue model

  1. Product Sales (Oral Care & Comfort Wear): Direct-to-consumer e-commerce sales of oral care products (toothpaste, mouth rinse, dry mouth candies, lip balm, remineralization gel, sensitive teeth kits, dry mouth kits) and comfort wear apparel (adaptive shirts, pants, hats, port protectors) for cancer patients. One-time purchase and subscription options available.
  2. Subscription Plans: Monthly subscription model delivering oral care kits every 30 days. Customers receive invoices with checkout links for recurring orders. Kits can be customized based on patient needs.
  3. Value-Based Care Partnerships (B2B): OSEM platform partnerships with health plans and pharma companies. Combines PMPM operating model with shared-savings alignment where Uncancer participates in upside only when documented cost reductions are achieved in oncology side effect management.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goIndividual oral care and comfort wear products
SubscriptionMonthlyMonthly subscription for oral care kits
OtherMulti-year contractOSEM Enterprise Value-Based Care Program

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Uncancer product offering

Product offering

Core offering

Uncancer sells doctor- and dentist-formulated oral care products and adaptive comfort apparel designed for people undergoing cancer treatment. The Oral Care (OC) line uses proprietary nHAP (nano-Hydroxyapatite) fluoride-free formulations to address chemo-induced dry mouth, tooth sensitivity, mucositis, and cracked lips. The Comfort Wear (CW) line provides adaptive clothing with port access and dignity features for treatment visits and everyday wear. Products are sold direct-to-consumer via a Shopify storefront with one-time purchase and monthly subscription options.

Product overview

Uncancer is a direct-to-consumer e-commerce company offering two integrated product collections — Oral Care (OC) and Comfort Wear (CW) — for cancer patients and their caregivers. The OC portfolio comprises nHAP fluoride-free oral care products (Sensitive Teeth Kit, Dry Mouth Kit, Dry Mouth Candies, Soothing Mouth Rinse, Toothpaste, Lip Balm, and Remineralization Gel) designed by doctors and dentists to address chemo-induced oral side effects. The CW portfolio consists of adaptive apparel (Adaptive Crew shirts for men and women, Comfort Shield, Flex Pant, Baseball Cap, and Cozy Beanie) engineered to ease treatment visits and accommodate medical devices. The company also operates OSEM™, a value-based care platform division serving health plans and pharma partners with claims-driven patient identification, home delivery of preventive products, RN navigation, and outcomes measurement. The broader offering includes educational blog content, stress-less checklists, and gift cards.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

  • 4,022 oncology patients enrolled in prior Cigna Medicare Advantage deployment with strong patient-reported symptom relief and satisfaction
  • +3 more outcomes

Companies that use Uncancer

Customer profile

Named customers2 records

Segments4 records

Ideal customer profiles4 records

Uncancer technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration6 records

Feature1 record

Uncancer partnerships and signals

Strategic signal

Partnerships

13 partnerships are on record, tiered core and minor.

  • Cigna Medicare AdvantagecoreStrategic or Co-development PartnerPrior national payer deployment enrolled 4,022 oncology patients under OSEM value-based care model. Generated strong patient-reported symptom relief and satisfaction outcomes. Demonstrated feasibility of preventive oral care intervention at scale.
  • Daiichi Sankyo + AstraZenecacoreStrategic or Co-development PartnerUncancer selected to support oral toxicity prevention for Dato-DXd, one of the highest oral-burden ADC therapies. Protocol activates at treatment initiation with no referral or prior authorization burden. Designed to protect treatment continuity.
  • Pink FundminorGTM or Marketing PartnerNon-profit organization providing financial support to breast cancer patients. Partner logo displayed on Uncancer trusted partners page.
  • Susan KomenminorGTM or Marketing PartnerBreast cancer organization. Partner logo displayed on Uncancer trusted partners page.
  • American Cancer SocietyminorGTM or Marketing PartnerVia Side Effect Support partnership. Partner logo displayed on Uncancer trusted partners page.
  • Oncology Nursing Society (ONS)minorGTM or Marketing PartnerProfessional organization for oncology nurses. Partner logo displayed on Uncancer trusted partners page.
  • Oral Cancer FoundationminorGTM or Marketing PartnerNon-profit dedicated to oral cancer awareness and support. Partner logo displayed on Uncancer trusted partners page.
  • SharsheretminorGTM or Marketing PartnerJewish breast cancer organization supporting women and families. Partner logo displayed on Uncancer trusted partners page.
  • Twisted PinkminorGTM or Marketing PartnerBreast cancer support organization. Partner logo displayed on Uncancer trusted partners page.
  • Fighting PrettyminorGTM or Marketing PartnerOrganization helping women feel fierce and beautiful during cancer treatment. Partner logo displayed on Uncancer trusted partners page.
  • BRCA StrongminorGTM or Marketing PartnerBRCA mutation awareness and support organization. Partner logo displayed on Uncancer trusted partners page.
  • Benco DentalminorGTM or Marketing PartnerDental distribution company. Partner logo displayed on Uncancer trusted partners page.
  • Cigna HealthcarecoreStrategic or Co-development PartnerCigna Starter Kit available for Cigna members. Partnership for providing oral care solutions to oncology patients.

Scale indicators5 records

Recent moves4 records

Expansion highlights5 records

Uncancer competitors and assessment

Company assessment

Emerging players

  • Thyme Care: Thyme Care is an oncology-focused value-based care navigation company working with health plans to reduce total cost of care for cancer patients. It is an adjacent emerging player in the same payer-facing oncology support category as Uncancer's OSEM division.
  • Pack Health: Pack Health is a digital health coaching company that partners with pharma and payers on condition-specific patient engagement and outcomes measurement. It overlaps with Uncancer's OSEM model in payer- and pharma-facing outcomes-driven engagement, though it does not focus on oncology oral care products.
  • Carifree: Carifree is a dental-products company focused on cavity prevention and remineralization technology, with professional dental channel distribution. It overlaps with Uncancer's nHAP remineralization positioning and is a relevant emerging player in the specialty oral care space.

Broad incumbents

  • Procter & Gamble (Oral-B / Crest): Procter & Gamble operates Crest and Oral-B, the leading mass-market oral care franchises with deep dental professional endorsement and clinical research infrastructure. It is the primary broad-incumbent competitor in the fluoride and sensitivity toothpaste category where Uncancer's OC Sensitive Teeth Kit competes.
  • Tom's of Maine: Tom's of Maine is a Colgate-Palmolive-owned natural oral care brand selling fluoride-free toothpaste and mouth rinses through mass retail. It is a broad incumbent in the same natural-ingredient oral care category as Uncancer's OC line, though it lacks the oncology-specific positioning.
  • Burt's Bees: Burt's Bees is a Clorox-owned natural personal care brand with adjacent lip balm and skincare offerings that overlap with Uncancer's OC Lip Balm and oral care portfolio. It is a broader incumbent rather than a direct oncology competitor, but competes for the same natural-ingredient-conscious buyer.
  • Colgate-Palmolive: Colgate-Palmolive is the dominant global oral care incumbent with extensive R&D, retailer relationships, and clinical programs. While it does not focus on oncology-specific formulations, its scale and ability to launch condition-specific sub-brands represent the primary competitive ceiling for Uncancer's OC line.

Direct peers

  • Boka: Boka is a direct-to-consumer oral care brand built around nano-hydroxyapatite (nHAP) fluoride-free formulations — the same core ingredient technology Uncancer uses. It targets mainstream consumers rather than oncology patients, but the formulation overlap, channel model, and ingredient positioning make it the closest comparable.
  • Care+Wear: Care+Wear is a direct-to-consumer adaptive apparel brand designed for patients undergoing medical treatment, including port access and recovery needs. It is the most directly comparable peer to Uncancer's Comfort Wear collection, competing in the same niche.
  • Hello Products: Hello is a natural-ingredient oral care brand selling toothpaste, mouth rinse, and breath products direct-to-consumer via e-commerce. It competes in the same natural, free-from positioning that Uncancer's OC line occupies, though without the oncology-specific clinical framing.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

Uncancer social profiles

Digital presence

Uncancer financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Uncancer leadership team

Management profile

Number of profiles

Profiles2 records

Uncancer funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Uncancer M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Uncancer

What does Uncancer do?

Uncancer sells doctor- and dentist-formulated oral care products and adaptive comfort apparel designed for people undergoing cancer treatment. The Oral Care (OC) line uses proprietary nHAP (nano-Hydroxyapatite) fluoride-free formulations to address chemo-induced dry mouth, tooth sensitivity, mucositis, and cracked lips. The Comfort Wear (CW) line provides adaptive clothing with port access and dignity features for treatment visits and everyday wear. Products are sold direct-to-consumer via a Shopify storefront with one-time purchase and monthly subscription options.

Is Uncancer a public or private company?

Uncancer is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Uncancer founded?

Uncancer was founded in 2020. It employs 1 to 10 people.

Where is Uncancer based?

Uncancer is headquartered in Clearwater, United States, in the North America region.

How does Uncancer make money?

Three revenue lines are on record. Product Sales (Oral Care & Comfort Wear) is the primary driver. The others are subscription Plans and value-Based Care Partnerships (B2B).

Who are Uncancer's main competitors?

Emerging players on record are Thyme Care, Pack Health and Carifree. Broad incumbents are Procter & Gamble (Oral-B / Crest), Tom's of Maine, Burt's Bees and Colgate-Palmolive. Direct peers are Boka, Care+Wear and Hello Products.

Does Uncancer have an API?

No public API is recorded for Uncancer.

What industry is Uncancer in?

Uncancer's product category is Oncology Support Products. Its primary akta.pro industry code is CRADAMAD, Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges). Its NAICS code is 456120 and its SIC code is 2844.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals